Rosa David A — SEC insider filings
SEC reporting owner CIK 1540354. 55 insider filings on record with FilingPulse; latest filed 2026-08-28.
Transaction summary — filings shown
Covers the 50 most recent of 55 filings on record, filed 2021-12-03 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 100,000 shares, $50,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 50.
- Largest priced transaction: purchase of 100,000 shares @ $0.50 ($50,000) in NEUROONE MEDICAL TECHNOLOGIES Corp, filed 2025-04-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | CEO & President, Director | 40 | 1 leg · 100,000 sh · $50,000 | — | 40 |
| BioRestorative Therapies, Inc. (BRTX) | Director | 4 | — | — | 5 |
| BIOTRICITY INC. (BTCY) | Director | 3 | — | — | 3 |
| Healthcare Triangle, Inc. (HCTI) | Director | 3 | — | — | 2 |
Insider filings — Rosa David A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Grant/award (A): 68,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,458 @ $0.78 | EDGAR |
| 2026-02-20 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 71,325 @ $0.68 | EDGAR |
| 2026-01-05 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,458 @ $0.76 | EDGAR |
| 2025-10-01 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,458 @ $0.89 | EDGAR |
| 2025-07-02 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,458 @ $0.68 | EDGAR |
| 2025-04-21 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Purchase (P): 100,000 @ $0.50 | EDGAR |
| 2025-04-02 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,458 @ $0.85 | EDGAR |
| 2025-02-20 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 71,325 @ $1.16 | EDGAR |
| 2025-02-19 | 4 | BioRestorative Therapies, Inc. (BRTX) | Grant/award (A): 52,632 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.15 | EDGAR |
| 2025-01-03 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 4,697 @ $0.83 | EDGAR |
| 2024-12-03 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $0.62 | EDGAR |
| 2024-11-01 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $0.97 | EDGAR |
| 2024-10-02 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 4,697 @ $0.99 | EDGAR |
| 2024-09-04 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $0.80 | EDGAR |
| 2024-08-02 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $0.75 | EDGAR |
| 2024-07-02 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 4,697 @ $0.80 | EDGAR |
| 2024-06-04 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $0.93 | EDGAR |
| 2024-05-02 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.13 | EDGAR |
| 2024-04-23 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 19,673 @ $1.15 | EDGAR |
| 2024-04-02 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.20 | EDGAR |
| 2024-03-13 | 4 | Healthcare Triangle, Inc. (HCTI) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.21 | EDGAR |
| 2024-02-21 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Grant/award (A): 663,497 @ $0 | EDGAR |
| 2024-02-15 | 4 | BioRestorative Therapies, Inc. (BRTX) | Grant/award (A): 79,646 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.25 | EDGAR |
| 2024-01-03 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.58 | EDGAR |
| 2023-12-04 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.45 | EDGAR |
| 2023-11-13 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Grant/award (A): 526,303 (derivative) @ $0 | EDGAR |
| 2023-11-03 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.61 | EDGAR |
| 2023-11-02 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $0.90 | EDGAR |
| 2023-10-03 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $0.89 | EDGAR |
| 2023-09-05 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $0.85 | EDGAR |
| 2023-08-01 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.02 | EDGAR |
| 2023-07-05 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.20 | EDGAR |
| 2023-06-01 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.21 | EDGAR |
| 2023-05-02 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.54 | EDGAR |
| 2023-04-25 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Grant/award (A): 91,500 @ $0 · Grant/award (A): 91,500 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 2,239 @ $1.61 | EDGAR |
| 2023-03-15 | 4 | BIOTRICITY INC. (BTCY) | Grant/award (A): 75,930 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | BioRestorative Therapies, Inc. (BRTX) | Grant/award (A): 32,028 (derivative) @ $0 | EDGAR |
| 2023-02-07 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Tax withholding (F): 53,750 @ $1.47 | EDGAR |
| 2023-01-30 | 4 | Healthcare Triangle, Inc. (HCTI) | Grant/award (A): 1 (derivative) @ $0 | EDGAR |
| 2022-11-04 | 4 | BioRestorative Therapies, Inc. (BRTX) | Disposition to issuer (D): 10,490 (derivative) @ $0 · Grant/award (A): 10,490 (derivative) @ $0 | EDGAR |
| 2022-09-09 | 4 | BIOTRICITY INC. (BTCY) | Grant/award (A): 31,106 (derivative) @ $0 | EDGAR |
| 2022-08-22 | 4 | Healthcare Triangle, Inc. (HCTI) | Holdings only — no transactions reported | EDGAR |
| 2022-02-04 | 4 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2021-12-03 | 4 | BIOTRICITY INC. (BTCY) | Grant/award (A): 27,174 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1540354 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs